◆ 会议时间：2025年5月26-30日
◆ 会议地点：罗马尼亚 布加勒斯特
◆ 会议简介：
2025年第43届欧洲儿科感染性疾病学会(ESPID)年会将于2025年5月26-30日在罗马尼亚布加勒斯特举行，届时将有来自世界各地的数千名儿科传染病学、流行病学和免疫学领域最杰出的研究人员、临床医生、住院医师等专业人士参会。
欧洲儿科感染性疾病学会(ESPID)的宗旨是通过举办科学会议与研讨会，组建国际学习小组和网络，出版杂志等形式促进小儿传染病领域具有特殊经验人员之间的信息交流；支持独立单位（如科室、部门等）的形成，促进儿科传染病学的发展；制定儿科传染病领域的标准和指南，在欧洲开展儿科感染病预防、诊断和治疗领域的宣合作研究；提供有关传染病和研究领域，特别是基础研究和临床护理方面的培训和继续教育；采取任何其他措施来支持促进儿科传染病学的研究（未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网-lingyuint.com）。
The 43rd Annual Meeting of the European Society for Paediatric Infectious Disease - ESPID 2025
Date: May 26 - 30, 2025
Venue: Bucharest, Romania
摘要征文投稿：
Key Dates
| Abstract Submission Opens |
10 October 2024 |
| Abstract Submission Deadline |
Tuesday, 21 January 2025 midnight CET (23:59) |
| Abstract Notifications* |
Mid-End February 2025 |
| Late-Breaking Submission Opens |
11 March 2025 |
| Late-Breaking Abstract Submission deadline |
25 March 2025 |
| Late-Breaking Abstract Notifications* |
Mid April 2025 |
点此提交摘要>>>Submit Abstract>>>
**Note all efforts are made to send notifications by the planned date. Should there be any delays with the selection process, the revised date will be posted here.
Participants interested in presenting their abstract at the Meeting are invited to submit their high-quality research via the abstract submission system. All abstracts will undergo peer review and may be accepted for presentation.
Please carefully read the guidelines below:
YOUR ABSTRACT PREFERENCE
1. Type Preference
In the abstract submission system, you choose one of the forms below which best describes the nature of your abstract. The selection of type will affect the information you are asked to provide within your abstract.
- Type 1: Regular Abstract.
- Type 2: Case Report/Case Series.
- Type 3: Walter Marget Workshop.
2. Topic & Presentation Preference
Once you select your abstract type and topic, you will choose from one of the below presentation preferences to submit your abstract to.
Please take note of the following information when selecting your presentation preference:
- Parallel Symposium: Your abstract will be considered for an oral presentation in the corresponding Parallel Symposium.
- Meet the Expert: Your case will be considered for an oral presentation in the corresponding Meet the Expert sessions. *Available for Case Report/Case Series type only.
- Oral Presentation/Poster Discussion: Your abstract will be considered for an e-poster and/or an oral presentation in the corresponding Oral Presentation Sessions or E-Poster Discussion Sessions.
- Walter Marget Workshop: Please click here for further guidelines.
- E-Poster Viewing
By selecting the relevant type, topic, and presentation preference for your abstract, you increase the likelihood of your preferred allocation and highest possible impact in the meeting.
RULES FOR SUBMISSION
Please read the submission rules before submitting an abstract.
- Only abstracts submitted via the online submission form will be sent to the Abstract Review Committee for review. Abstracts submitted by fax or e-mail will not be accepted.
- The Scientific Programme Committee will endeavour to schedule abstracts according to authors’ preferences but reserves the right to decide on the final form of presentation.
- Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
- Limitations:
- The same person may submit multiple abstracts regardless of presenting author.
- The same person may serve as the presenting author on up to 5 abstracts.
- Presenting authors of abstracts must be registered and paid participants.
- The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Meeting.
- All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facilities) or by a copy editor, prior to submission.
- Abstracts must be original and must not be or have been published or presented at any other meeting prior to the 41st Annual Meeting of ESPID.
- ESPID will publish all accepted abstracts online (open access) for a period of at least 5 years. As a condition of submission, ESPID requires you to agree to such publication and to surrender any copyright over the abstract as submitted to ESPID.
- Abstracts stating “data will be discussed in the presentation” will NOT be accepted.
- Abstract submitters will be required to disclose any conflict of interests in the submission form.
- Instructions for the preparation of presentations will be made available on the meeting website.
GUIDELINES FOR SUBMISSION
Before you submit your abstract, please prepare the following information:
- Presenting author’s contact details (should be the same details as the submitting author so that the presenting author receives the correspondence about the abstract):
- Full first and family name(s)
- Email address
- Affiliation details: department, institution / hospital, city, state (if relevant), country
- Author and co-authors’ details
- Selection of Type (abstract type) and preferred Topic.
- Abstract title – Limited to 25 words in UPPER CASE
- Abstract text – Limited to 280 words including acknowledgments. We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words. Please note, word count is affected when tables are included.
- Tables and Images – You are able to add one table/figure per abstract. Tables and images can only be placed in certain sub-sections of your abstract, according to your stream preference. The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload graphs and images in JPEG, GIF, or PNG format. Please note that images/tables may be resized to fit in the final material.
- Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appears the first time.
- Use generic names of drugs. Express numbers as numerals. The presentation must be balanced and contain no commercial promotional content.
- Submissions may not contain patient names, hospital ID numbers, or other identifying information.
- The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline, if not submitted, drafts will be deleted.
- Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
- You will receive an abstract ID number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
- Please contact us if you have not received confirmation that your abstract has been submitted.
- Please do not submit multiple copies of the same abstract.
ESPID AI Abstract Assistant
Introducing our new ESPID AI Abstract Review Assistant! Elevate your submission process by logging in to receive intelligent feedback on your abstract before initiating the submission. Paste your abstract text into the AI interface for comprehensive pre-submission insights and suggestions.
DISCLOSURE
Disclosure of financial relationships that the author(s) may have with the manufacturer/supplier of any commercial products or services related to the work, should be indicated in the appropriate tick box on the abstract form.
ABSTRACT SUBMITTERS’ DECLARATION
During abstract submission you will be asked to confirm that you agree to the following:
- I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.
- Submission of the abstract constitutes the consent of all authors to publication (e.g. Conference website, programs, other promotions, etc.)
- The abstract submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to ESPID and Kenes International Organizers of Congresses SA and its affiliates (together: the “Organizers“), nor the publication of any such Content by each of the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
- The Abstract Submitter grants each of the Organizers the license and right to use, reproduce, publish, translate, distribute, and display the Content or any part thereof, in any manner and on any platform or media whatsoever, in each Organizer’s absolute discretion, on a royalty-free, perpetual, irrevocable nonexclusive basis.
- I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on the abstract correspondence.
- I understand that the presenting author must be a registered participant.
- The Organizers reserve the right to remove from publication and/or presentation an abstract that does not comply with the above.
- I understand that I must select a specific Topic and Sub-Topic for my abstract allocation. Although the Committee will work hard to honour this selection, this cannot be guaranteed. The Committee reserves the right to change the Topic and Sub-Topic under which the abstract was originally submitted.
Dear Colleagues and friends,
Buna ziua,
On behalf of the Local Organizing Committee and the International Scientific Committee, it gives us a great pleasure to welcome you at the 43rd Annual meeting of the European Society of Paediatric Infectious Disease Society, which will be held between 26th to 30th May 2025 in Bucharest, Romania.
ESPID 2025 participants will have the opportunity to attend lectures given by world renowned researchers and scientists that are experts in the field of pediatric infectious disease as well as in other disciplines such as genomics, pharmacology, immunology, gastrointestinal diseases, allergology, public health. ESPID 2025 will also provide the opportunity to participants to present their research, to exchange ideas and interact with all colleagues that share common interests in paediatric infectious disease field. It also offers the opportunity to establish new collaborations between different centers, as well as to reinforce the existing ones. We encourage you to submit your work and share with us all your research interests.
During these challenging times, we hope that our ESPID meeting will provide a link between the Eastern and Western part of Europe that will unite us in our common interest, the health and well-being of our children.
We are planning a social program that will allow you to experience the warmth and welcoming charm of our capital Bucharest and also of the Romanian people.
We are absolutely delighted to welcome you in Bucharest. We hope that you will be involved in all the aspects of the scientific as well as of the social events that ESPID 2025 will offer.
With best wishes,
Oana Falup-Pecurariu
Chair of ESPID 2025
Emmanouil Galanakis
ESPID President
Adilia Warris
ESPID President-Elect
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
